| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
20,830 |
17,605 |
$731K |
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
255 |
239 |
$424K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,123 |
6,287 |
$350K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,769 |
6,178 |
$220K |
| Q9991 |
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
118 |
112 |
$216K |
| J0578 |
Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy |
110 |
109 |
$178K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,167 |
2,047 |
$71K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,692 |
1,690 |
$68K |
| J0576 |
Injection, buprenorphine extended-release (brixadi), 1 mg |
59 |
59 |
$62K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,382 |
2,357 |
$26K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
664 |
662 |
$25K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,088 |
3,058 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
196 |
194 |
$9K |
| 96127 |
|
3,289 |
3,025 |
$9K |
| 80305 |
|
1,597 |
1,275 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,240 |
1,138 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
87 |
82 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
668 |
667 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
123 |
122 |
$2K |
| 90686 |
|
816 |
813 |
$1K |
| 90670 |
|
1,022 |
1,018 |
$954.13 |
| 90474 |
|
89 |
89 |
$758.75 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
54 |
53 |
$329.02 |
| 90473 |
|
202 |
202 |
$255.84 |
| 96160 |
|
63 |
60 |
$113.28 |
| 96161 |
|
80 |
78 |
$64.02 |
| 90707 |
|
166 |
166 |
$0.00 |
| 90648 |
|
880 |
877 |
$0.00 |
| 90633 |
|
196 |
195 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
135 |
128 |
$0.00 |
| 90685 |
|
25 |
25 |
$0.00 |
| 90734 |
|
12 |
12 |
$0.00 |
| 90723 |
|
686 |
684 |
$0.00 |
| 90716 |
|
161 |
160 |
$0.00 |
| 90677 |
|
66 |
66 |
$0.00 |
| 90680 |
|
540 |
538 |
$0.00 |
| 90697 |
|
12 |
12 |
$0.00 |
| 90656 |
|
12 |
12 |
$0.00 |
| 90651 |
|
12 |
12 |
$0.00 |